Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.

Autor: Zakhour, Ramia, Tran, Dat Q., Degaffe, Guenet, Bell, Cynthia S., Donnachie, Elizabeth, Weihe Zhang, Pérez, Norma, Benjamins, Laura J., Del Bianco, Gabriela, Rodriguez, Gilhen, Murphy, James R., Heresi, Gloria P.
Předmět:
Zdroj: Clinical Infectious Diseases; 4/15/2016, Vol. 62 Issue 8, p1029-1035, 7p
Abstrakt: Background. Robust immune restoration in human immunodeficiency virus (HIV)-positive patients is dependent on thymic function. However, few studies have investigated thymic function and its correlation with disease progression over time in HIVpositive patients. Methods. In this longitudinal prospective study, we followed 69 HIV-positive patients who were perinatally infected. Peripheral blood mononuclear cells were stained with monoclonal anti-CD4 and anti-CD31 and recent thymic emigrants (CD4+recently emigrated from the thymus (RTE), CD4+CD31+) quantified by flow cytometry. Statistical analysis used Wilcoxon rank sum test, Kruskal-Wallis, Spearman correlation, and Kaplan-Meier estimates; Cox regression models were performed for the longitudinal analysis. Results. Median age of HIV positive patients enrolled was 13 years (interquartile range [IQR], 8.6). CD4+RTE% decreased with age and was higher in females. Median CD4+RTE% was 53.5%, IQR, 22.9. CD4+RTE% was closely related to CD4+% and absolute counts but independent of viral load and CD8+CD38+%. Antiretroviral compliance as well as higher nadir CD4+% were associated with higher CD4+RTE%. Low CD4+RTE% predicted poor progression of VL and CD4+% over time. Conclusions. CD4+RTE% predicts disease progression and may reflect history of disease in HIV-positive patients and adolescents. They are easy to measure in the clinical setting and may be helpful markers in guiding treatment decisions. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index